BLINKBIO, INC.

Profile

Company Names

BLINKBIO, INC.
COFERON, INC.

Addresses

1061 OCEAN DRIVE, JUNO BEACH, FL 33408

SUITE 165, ALEXANDRIA INNOVATION CENTER, 555 HERITAGE DRIVE, JUPITER, FL 33458

C/O THE SCRIPPS RESEARCH INSTITUTE, 130 SCRIPPS WAY #2B2, JUPITER, FL 33458

25 HEALTH SCIENCES DRIVE, MAILBOX 123, STONY BROOK, NY 11790

C/O ARGENT VENTURES, 551 FIFTH AVENUE, 34TH FLOOR, NEW YORK, NY 10176

Phone Numbers

800-983-8098
212-692-5400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$43,623,699.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2019-05-07 
$525,000.00 
$525,000.00 
$0.00 
Debt 
11
2018-12-18 
$1,275,000.00 
$1,275,000.00 
$0.00 
Debt 
10
2018-06-12 
$808,394.00 
$20,000,000.00 
$19,191,606.00 
Equity 
9
2016-09-09 
$19,143,368.00 
$19,143,368.00 
$0.00 
Equity 
8
2015-08-05 
$1,006,067.00 
$5,000,000.00 
$3,993,933.00 
Debt 
7
2014-10-10 
$4,000,000.00 
$4,000,000.00 
$0.00 
Debt 
6
2014-05-07 
$1,000,000.00 
$1,000,000.00 
$0.00 
Debt 
5
2012-06-20 
$5,495,237.00 
$11,999,997.00 
$6,504,760.00 
Equity 
4
2012-01-31 
$50,000.00 
$441,008.00 
$391,008.00 
Debt 
3
2011-12-08 
$216,658.00 
$750,000.00 
$533,342.00 
Debt 
2
2011-05-04 
$2,999,975.00 
$2,999,975.00 
$0.00 
Equity 
1
2009-07-31 
$7,104,000.00 
$8,468,000.00 
$1,364,000.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KAPIL 
 
DHINGRA 
DIRECTOR
COFERON, INC.   |  EXOSOME DIAGNOSTICS, INC.
MICHAEL 
 
GARGANO 
DIRECTOR
COFERON, INC.   |  BLINKBIO, INC.   |  ACUAMARK DIAGNOSTICS, INC.
COLIN 
 
GODDARD 
EXECUTIVE OFFICER, DIRECTOR
ZELOS THERAPEUTICS INC   |  COFERON, INC.   |  PANOPTICA, INC.   |  MERGANSER BIOTECH, INC.   |  BLINKBIO, INC.   |  OS THERAPIES INC
ALAN 
 
LEWIS 
DIRECTOR
COFERON, INC.   |  BATU BIOLOGICS, INC.   |  JF LAND HOLDINGS II, LLC   |  DIAVACS, INC.   |  JF BONNEVILLE, LLC   |  DIVERSYFUND MONTEREY, LLC   |  DIVERSYFUND BALBOA, LLC   |  DIVERSYFUND PARK BLVD, LLC   |  DIVERSYFUND, INC.   |  PALADIN TECHNOLOGIES, INC.   |  DIVERSYFUND INCOME FUND, LLC   |  DF SUMMERLYN, LLC   |  DF KENWOOD, LLC   |  HEMET BANCORP   |  DF INDEPENDENT PARTNERS LLC   |  DF DISTRESSED OPPORTUNITIES FUND, LLC
VIREN 
 
MEHTA 
DIRECTOR
ONCONOVA THERAPEUTICS INC   |  ONCONOVA THERAPEUTICS, INC.   |  COFERON, INC.   |  BLINKBIO, INC.
MANEESH 
 
PINGLE 
EXECUTIVE OFFICER
BLINKBIO, INC.
DOUGLAS 
 
REED 
DIRECTOR
SPINEWORKS MEDICAL INC   |  SPINEALIGN MEDICAL INC   |  VIAMET PHARMACEUTICALS INC   |  PHASEBIO PHARMACEUTICALS INC   |  TETRALOGIC PHARMACEUTICALS CORP   |  HATTERAS VENTURE PARTNERS IV, LP   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  NEUROTRONIK, INC.   |  SIDERIS PHARMACEUTICALS, INC.   |  COFERON, INC.   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  BLINKBIO, INC.   |  HATTERAS VENTURE PARTNERS V, LP   |  QPEX BIOPHARMA, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  EMX ROYALTY CORP   |  AVIVOMED INC.   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC
JAMES 
 
SCHULZ 
EXECUTIVE OFFICER
NAUREX INC.   |  COFERON, INC.   |  ANAGIN, INC.   |  SCIOTO BIOSCIENCES, INC.   |  FIRST STATE HOLDING CO.
MARK 
 
SIMON 
DIRECTOR
COFERON, INC.   |  HYDRO PHI TECHNOLOGIES, INC.   |  MIG IRC, LLC   |  INTELLIRAD CONTROL, INC.   |  TATOOSH DISTILLERY, LLC   |  CONTROLRAD SYSTEMS, INC.   |  CONTROLRAD, INC.   |  NORTHWEST NUTRITIONAL FOODS LLC   |  CABALETTA BIO, INC.   |  PORTAGE BIOTECH INC.   |  GLMPS CO.
DEREK 
 
SMALL 
EXECUTIVE OFFICER, DIRECTOR
NAUREX INC.   |  COFERON, INC.   |  ANAGIN, INC.   |  GATE NEUROSCIENCES, INC.
GEOFF 
 
SMITH 
DIRECTOR
COFERON, INC.   |  BLINKBIO, INC.   |  CAREDOX INC.   |  APTON BIOSYSTEMS, INC.   |  COSA RESOURCES CORP.
JUTTA 
 
WANNER 
EXECUTIVE OFFICER
BLINKBIO, INC.   |  OS THERAPIES INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-07-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-05-07 
2019-04-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-12-18 
2018-06-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-12 
2017-07-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-09 
2017-03-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-09 
2016-09-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-09 
2015-08-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-08-05 
2014-10-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-10-10 
2014-05-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-05-07 
2012-07-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-20 
2012-02-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-01-31 
2011-12-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-12-08 
2011-05-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-04 
2011-01-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-07-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NOBLE LIFE SCIENCE PARTNERS
15768
NONE
NONE
NOBLE LIFE SCIENCE PARTNERS
15768